Parkinsn's Email List Message

Posting to the Parkinsn List is a benefit of Subscription

[Message Prev][Message Next][Thread Prev][Thread Next][Message Index][Thread Index]

NEWS: New clinical trial to test neuroprotective substances

Here is a summary of a PR releases found at


Neurology Professor Karl Kieburtz, M.D., of the University of
Rochester will lead the biggest clinical trial ever of Parkinson?s
disease.  Starting late 2002 or in 2003, 3000 PD patients will be
tracked at 42 sites for 5 years to determine the effectiveness of
various substances at slowing the progression of the disease.  The
study will be supported by a $6.5 million grant from the National
Institute of Neurological Disorders and Stroke (NIH Grant number
1U01NS43128-01).

Phil Tompkins

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:listserv@xxxxxxxxxxxxxxxxxxxx
In the body of the message put: signoff parkinsn

Parkinsn's List Subject Index

Parkinsn's List Thread Index

Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.

Mail converted by MHonArc 2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance